tiprankstipranks
Advertisement
Advertisement

H.B. Fuller Earnings Call: Margins Up, Volumes Down

H.B. Fuller Earnings Call: Margins Up, Volumes Down

H.B. Fuller Company ((FUL)) has held its Q1 earnings call. Read on for the main highlights of the call.

Claim 55% Off TipRanks

H.B. Fuller’s latest earnings call struck a cautiously constructive tone as management weighed soft volumes, supply disruption and raw‑material inflation against clear progress on margins, cash generation and cost savings. Executives stressed that upgraded guidance rests on decisive pricing and disciplined execution rather than an improving demand backdrop, keeping investor expectations grounded.

Profitability and Margin Expansion

H.B. Fuller delivered adjusted EBITDA of $119,000,000, up 4% year over year, with margins rising to 15.4% as pricing, mix and cost actions offset weaker volumes. Adjusted gross margin improved 170 basis points to 31.3%, while adjusted EPS climbed 6% to $0.57, underscoring that profitability is moving ahead even as the top line shrinks.

Raised Full‑Year Guidance

Management raised full‑year 2026 guidance, now calling for mid‑single‑digit net revenue growth and low‑single‑digit organic growth, helped by a 1–2% FX tailwind. Adjusted EBITDA is forecast between $645,000,000 and $675,000,000 and adjusted EPS between $4.55 and $4.90, with Q2 revenue seen up low single digits and EBITDA at $175,000,000–$185,000,000.

Decisive Pricing Actions

To combat raw‑material inflation, H.B. Fuller announced a minimum 10% global price increase across all product lines effective April 1, with larger hikes in certain technologies and regions. Management expects 10% or more realized pricing for the rest of the year, positioning pricing as a key lever behind the higher earnings outlook.

Cash Flow and Balance Sheet Discipline

Operating cash flow improved by $49,000,000 versus a year ago, helping the company trim net debt to adjusted EBITDA to 3.1x from 3.5x. Capital allocation is tilting toward share repurchases in the near term while management continues to target leverage in the 2.5x–3.0x range, signaling a focus on balance sheet resilience.

Strength in Engineering Adhesives

The Engineering Adhesives segment remained a bright spot, with organic revenue up about 3% excluding solar and down only 2% including solar. EA EBITDA rose 9% and the segment’s margin expanded 120 basis points to 19.9%, highlighting the profitability of this higher‑value portfolio.

Sourcing Capabilities Drive Share Opportunities

As supply chains tightened, H.B. Fuller leaned on its global sourcing and supply‑assurance capabilities, securing additional raw materials despite Middle East disruptions. Management reported that several large global customers have turned to the company for incremental supply, creating near‑term share‑gain opportunities.

Project Quantum Leap and Cost Savings

Restructuring efforts and Project Quantum Leap remain central to the margin story, with expected benefits for the year raised from $10,000,000 to $15,000,000. These initiatives are helping offset volume pressure and underpin the expansion in gross and EBITDA margins.

Regional and Specialty Growth Pockets

Not all markets are soft, with Asia Pacific organic revenue up around 2% excluding solar despite a $15–$20 million Q1 drag from Chinese New Year timing. The company also highlighted roughly 20% organic growth in European medical, plus ongoing strength in aerospace and general industries in the Americas, which delivered about 8% growth.

Top‑Line and Volume Pressure

Despite pricing gains, consolidated organic revenue fell 6.6% year over year in Q1, with pricing up 0.6% but volume down 7.2%. Including solar, organic revenue declined about 6%, underscoring that underlying demand and availability of inputs remain headwinds.

Health & Hygiene Segment Under Strain

The Health & Hygiene segment posted a 10% organic revenue decline as customers tightened inventories and consumers traded down to lower‑cost products and smaller pack sizes. These shifts reduce adhesive usage per end product, pressuring volumes in what is typically a stable category.

Regional Weakness in EIMEA and BAS

EIMEA organic revenue slid 11% and the BAS business saw organic sales fall 5.1%, with BAS EBITDA down about 1% and margins flat, reflecting challenging conditions in these markets. In the Americas, organic revenue was down 4%, though aerospace and general industries provided a partial offset with solid growth.

Severe Supply Chain Disruption and Inflation

The company received more than 40 force majeure notices, flagging broad‑based raw‑material shortages and sharp inflation, including a roughly 300% spike in European VAM spot prices. Management noted that finished‑goods costs are rising anywhere from around 10% to as much as 40–50% in some cases, making pricing and sourcing central to the strategy.

Solar Business Weakness

Solar‑related revenue was about $12.5 million in the quarter, down roughly 40%, and remains a drag, though limited to about 1% at the company level and around 4% in EA. Management expects the solar trough to continue through Q3 as it exits or scales back exposure to that end market.

Lower Volume Outlook and Inventory Risks

Management cut its volume outlook for the year from near flat to down about 5%, citing demand softness and substrate and raw‑material constraints despite anticipated share gains. Customers and distributors are running lean inventories, and H.B. Fuller may hold more inventory to secure supply, which raises working‑capital risk and skews cash flow to the second half.

Pause in M&A Activity

Given petrochemical market disruption and broader uncertainty, the company is pausing near‑term acquisitions and rechanneling some capital into share repurchases. This temporary shift reduces near‑term inorganic growth but preserves financial flexibility while conditions remain volatile.

Guidance and Outlook

Looking ahead, H.B. Fuller’s updated 2026 guidance banks on mid‑single‑digit net revenue growth, low‑single‑digit organic growth and adjusted EBITDA of $645,000,000–$675,000,000, with EPS of $4.55–$4.90. The forecast assumes more than 10% pricing, about a 5% volume decline, incremental restructuring benefits, second‑half‑weighted cash generation and stable leverage as M&A pauses and buybacks increase.

The earnings call framed H.B. Fuller as a company navigating a tough demand and supply backdrop with strong pricing power, cost discipline and sourcing capabilities. While volume declines, segment pressures and supply‑chain risk keep the outlook guarded, investors heard a clear message that margin expansion, higher guidance and share‑gain opportunities remain firmly in play.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1